Diagnosis and management of malignant pleural effusions: state of the art in 2017.

about

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Item

http://www.wikidata.org/entity/Q46481901

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@en

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@nl

type

Item

label

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@en

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@nl

prefLabel

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@en

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@nl

P1476

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

@en

P2093

Hans J Lee

http://www.w3.org/2001/XMLSchema#string

Neeraj R Desai

http://www.w3.org/2001/XMLSchema#string

P2860

Pleurodesis for malignant pleural effusions

Screening Performance Characteristic of Ultrasonography and Radiography in Detection of Pleural Effusion; a Meta-Analysis

Thoracoscopy: medical versus surgical-in the management of pleural diseases

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial

Pneumothorax following thoracentesis: a systematic review and meta-analysis

Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010

Patient evaluation for rapid pleurodesis of malignant pleural effusions

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

Prognostic significance of pleural fluid data in patients with malignant effusion.

P304

S1111-S1122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.21037/JTD.2017.07.79

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 10

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214068

http://www.w3.org/2001/XMLSchema#string

P932

5696546

http://www.w3.org/2001/XMLSchema#string